Led, you missed my point regarding renal.  I said that I think it is a big miss by management not to have moved renal along faster in order to have more strings to the bow so to speak. That being said they could still partner with someone on this aspect. 

As far as serious financial difficulty goes it will be interesting to see in the quarterly financials just how serious it is.  We all know they have been running lean but I suspect the board now claiming this is mostly a way to avoid a voting requirement on this loan remedy. There was simply no time to vote without going into default and that would have been very serious.